Literature DB >> 2125177

IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis.

T M Chiller1, M A Samudio, G Zoulek.   

Abstract

Sera from 38 Paraguayans with positive skin tests to Leishmania braziliensis panamensis and 51 sera from Paraguayan patients in different stages of Chagas' disease were analyzed by Western blotting using antigen from Trypanosoma cruzi Y strain epimastigotes and from L. b. panamensis promastigotes. Using a single serum sample, distinctive patterns of IgG antibody response to both antigens were identified allowing the differentiation between T. cruzi infection, Leishmania infection, and probable double infection. Sera from patients with T. cruzi infections consistently recognized bands of approximately 25 kDa, 38 kDa, and greater than 97 kDa in T. cruzi antigen lysates and recognized a band of 38 kDa of 66 kDa in Leishmania antigen lysates but did not consistently recognize any bands using T. cruzi antigen. Sera from patients with probable double infections recognized all bands normally detected by individual sera from patients infected with either T. cruzi or Leishmania. In our study population, T. cruzi infection among leishmaniasis patients was as frequent as among individuals free of leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125177     DOI: 10.4269/ajtmh.1990.43.650

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

1.  Performance of immunoblotting in diagnosis of visceral Leishmaniasis in human immunodeficiency virus-Leishmania sp.-coinfected patients.

Authors:  G Santos-Gomes; S Gomes-Pereira; L Campino; M D Araújo; P Abranches
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Serological diagnosis of Chagas' disease: a potential confirmatory assay using preserved protein antigens of Trypanosoma cruzi.

Authors:  R P Mendes; S Hoshino-Shimizu; A M Moura da Silva; I Mota; R A Heredia; A O Luquetti; P G Leser
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America.

Authors:  E S Umezawa; S F Bastos; M E Camargo; L M Yamauchi; M R Santos; A Gonzalez; B Zingales; M J Levin; O Sousa; R Rangel-Aldao; J F da Silveira
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Enzyme-linked immunosorbent assay for serological diagnosis of Chagas' disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides.

Authors:  A W Ferreira; Z R Belem; E A Lemos; S G Reed; A Campos-Neto
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease.

Authors:  W M Oelemann; M D Teixeira; G C Veríssimo Da Costa; J Borges-Pereira; J A De Castro; J R Coura; J M Peralta
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

6.  Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).

Authors:  E L Malchiodi; M G Chiaramonte; N J Taranto; N W Zwirner; R A Margni
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

7.  Recombinant Leishmania Hsp90 and Hsp70 are recognized by sera from visceral leishmaniasis patients but not Chagas' disease patients.

Authors:  C R de Andrade; L V Kirchhoff; J E Donelson; K Otsu
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

8.  Polymerase chain reaction-based detection of Trypanosoma cruzi DNA in serum.

Authors:  G Russomando; A Figueredo; M Almirón; M Sakamoto; K Morita
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  Trypanosoma cruzi recombinant complement regulatory protein: a novel antigen for use in an enzyme-linked immunosorbent assay for diagnosis of Chagas' disease.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

10.  Identification of an immunodominant 32-kilodalton membrane protein of Leishmania donovani infantum promastigotes suitable for specific diagnosis of Mediterranean visceral leishmaniasis.

Authors:  F Tebourski; A el Gaied; H Louzir; R Ben Ismail; R Kammoun; K Dellagi
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.